ATE254177T1 - Staphylococcus aureus v8 protease mutanten - Google Patents

Staphylococcus aureus v8 protease mutanten

Info

Publication number
ATE254177T1
ATE254177T1 AT96303939T AT96303939T ATE254177T1 AT E254177 T1 ATE254177 T1 AT E254177T1 AT 96303939 T AT96303939 T AT 96303939T AT 96303939 T AT96303939 T AT 96303939T AT E254177 T1 ATE254177 T1 AT E254177T1
Authority
AT
Austria
Prior art keywords
urea
concentrations
enzyme
staphylococcus aureus
protease mutants
Prior art date
Application number
AT96303939T
Other languages
English (en)
Inventor
Masayuki Yabuta
Kazuhiro Ohsuye
Original Assignee
Daiichi Suntory Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Suntory Pharma Co Ltd filed Critical Daiichi Suntory Pharma Co Ltd
Application granted granted Critical
Publication of ATE254177T1 publication Critical patent/ATE254177T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Materials For Medical Uses (AREA)
  • Detergent Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Prostheses (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT96303939T 1995-06-02 1996-05-31 Staphylococcus aureus v8 protease mutanten ATE254177T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP17008695 1995-06-02

Publications (1)

Publication Number Publication Date
ATE254177T1 true ATE254177T1 (de) 2003-11-15

Family

ID=15898392

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96303939T ATE254177T1 (de) 1995-06-02 1996-05-31 Staphylococcus aureus v8 protease mutanten

Country Status (9)

Country Link
US (1) US5747321A (de)
EP (1) EP0745669B1 (de)
JP (1) JP3852982B2 (de)
KR (1) KR100650960B1 (de)
AT (1) ATE254177T1 (de)
DE (1) DE69630630T2 (de)
ES (1) ES2206546T3 (de)
HU (1) HUP9601487A3 (de)
IL (2) IL118473A0 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1090132A1 (de) * 1998-06-26 2001-04-11 PPL Therapeutics (Scotland) Limited Verfahren zur herstellung von rekombinanten polypetide
CA2380058C (en) 1999-07-23 2011-08-09 Kenji Kangawa Novel peptides
EP2206786A1 (de) * 1999-08-31 2010-07-14 Novozymes A/S Neue Proteasen und Varianten davon
US6558939B1 (en) * 1999-08-31 2003-05-06 Novozymes, A/S Proteases and variants thereof
US7217554B2 (en) * 1999-08-31 2007-05-15 Novozymes A/S Proteases and variants thereof
ATE430799T1 (de) * 1999-10-19 2009-05-15 Bharat Biotech International L Expression von rekombinantem, reifem lysostaphin
EP1493747B1 (de) 2002-04-11 2012-12-19 Daiichi Sankyo Company, Limited Verfahren zur herstellung von modifiziertem peptid

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2017379C (en) * 1989-05-24 2002-06-25 Kenneth A. Thomas, Jr. Purification and characterization of a glioma-derived growth factor
US5536655A (en) * 1989-09-26 1996-07-16 Midwest Research Institute Gene coding for the E1 endoglucanase
ATE253639T1 (de) * 1991-08-19 2003-11-15 Daiichi Suntory Pharma Co Ltd Verfahren zur herstellung von peptiden

Also Published As

Publication number Publication date
HU9601487D0 (en) 1996-08-28
JP3852982B2 (ja) 2006-12-06
DE69630630D1 (de) 2003-12-18
IL118473A (en) 2005-03-20
DE69630630T2 (de) 2004-09-23
US5747321A (en) 1998-05-05
KR100650960B1 (ko) 2007-03-02
HUP9601487A3 (en) 2001-08-28
EP0745669A2 (de) 1996-12-04
EP0745669A3 (de) 1999-05-26
ES2206546T3 (es) 2004-05-16
EP0745669B1 (de) 2003-11-12
JPH0947291A (ja) 1997-02-18
IL118473A0 (en) 1996-09-12
HUP9601487A2 (en) 1997-05-28
KR970001536A (ko) 1997-01-24

Similar Documents

Publication Publication Date Title
Kitamoto et al. Hen egg white ovomacroglobulin has a protease inhibitory activity
DE69628656D1 (de) Mannase von bacillus amyloliquefaciens und methode zu ihrer preparation
Moura-da-Silva et al. Evidence for heterogeneous forms of the snake venom metalloproteinase jararhagin: a factor contributing to snake venom variability
ATE203056T1 (de) Thermostabile dna polymerase aus thermoanaerobacter thermohydrosulfuricus und davon abgeleitete mutierte enzyme mit entfernter exonukleaseaktivität
DE60133802D1 (de) Verwendung von säurestabilen proteasen in tierfutter
DK204290D0 (da) Enzymatisk detergentkomposition og fremgangsmaade til enzymstabilisering
MXPA06001173A (es) Metodo analitico para la pancreatina y composiciones comparables.
MA23330A1 (fr) Serine protease a absorption diminuee et hydrolyse accrue .
DE69534467D1 (de) Modifikation des starke-gehalts in pflanzen
DK0506791T3 (da) Enzymholdigt præparat og detergent indeholdende et sådant præparat
TR199902751T2 (xx) Proteaz inhibit�rleri.
SE8902532L (sv) Bestaemning av plasmaproteiner
DE69630630D1 (de) Staphylococcus aureus V8 Protease Mutanten
Huang et al. Formation of enzymatically active, homotypic, and heterotypic tetramers of mouse mast cell tryptases: dependence on a conserved Trp-rich domain on the surface
Guillin et al. The mechanism of activation of human prothrombin by an activator isolated from Dispholidus typus venom
FI934305A0 (fi) Dipeptidylaminopeptidas fraon dictyostelium
DE69736076D1 (de) Enzyme mit s-adenosyl-l-homocystein-hydrolase-ähnlicher aktivität.
ES2060202T3 (es) Composicion detergente enzimatica liquida.
Gudzenko et al. Isolation and characterization of Bacillus sp. IMV B-7883 proteases
FI925676A0 (fi) Vaermestabil proteas fraon staphylothermus
DK0667872T3 (da) Mutantinterleukin 6 med forbedret biologisk aktivitet i forhold til vildtype-interleukin 6
Arima et al. Cleavage specificity of cucumisin, a serine protease, with synthetic substrates
Sakharov et al. Purification and some properties of elastase from hepatopancreas of king crab Paralithodes camtschatica
PT99578A (pt) Processo para a reactivacao de uma proteina desnaturada
Torres et al. Bmoo FIBMP‐I: A New Fibrinogenolytic Metalloproteinase from Bothrops moojeni Snake Venom

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0745669

Country of ref document: EP

EEIH Change in the person of patent owner